foxo4-dri peptide senolytic 2023 Development of a novel by precise disruption of FOXO4-p53 complex Molecular modelling of the FOXO4-TP53
Description
In: Gibson M, editor
J Pharmacol Sci 108(1):717 Cesarec V, Becejac T, Misic M, Djakovic Z, Olujic D, Drmic D et al (2013) Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy
Management of post-acute COVID-19 in primary care
GEMINI 1 and 2 phase III trials showed that tolebrutinib was not superior to teriflunomide in reducing relapses, but there was a reduction in 6-month confirmed disability progression, although this was not formally tested (80)
